The Federal Biotechnology Workforce Assessment Act directs the Director of the Office of Personnel Management (OPM) to conduct a comprehensive assessment of the biotechnology workforce needs across numerous federal agencies. This assessment, performed in coordination with agency heads, will identify both current and projected biotechnology positions required over 5-year and 10-year periods. Key aspects of the assessment include detailing the roles and qualifications for these positions, quantifying necessary security clearances and associated funding, and evaluating OPM's current classification systems for biotechnology roles. The bill also requires identifying challenges in workforce development and proposing solutions, alongside assessing the effectiveness of internal training, inter-agency detailing, and leveraging public-private talent exchanges . Furthermore, it mandates exploring mechanisms to access external biotechnology expertise, including prequalified experts with necessary security clearances. OPM must submit a report summarizing these findings and recommendations to relevant congressional committees within 180 days of the Act's enactment.
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the House Committee on Oversight and Government Reform.
Introduced in House
Referred to the House Committee on Oversight and Government Reform.
Science, Technology, Communications
Federal Biotechnology Workforce Assessment Act
USA119th CongressHR-8930| House
| Updated: 5/20/2026
The Federal Biotechnology Workforce Assessment Act directs the Director of the Office of Personnel Management (OPM) to conduct a comprehensive assessment of the biotechnology workforce needs across numerous federal agencies. This assessment, performed in coordination with agency heads, will identify both current and projected biotechnology positions required over 5-year and 10-year periods. Key aspects of the assessment include detailing the roles and qualifications for these positions, quantifying necessary security clearances and associated funding, and evaluating OPM's current classification systems for biotechnology roles. The bill also requires identifying challenges in workforce development and proposing solutions, alongside assessing the effectiveness of internal training, inter-agency detailing, and leveraging public-private talent exchanges . Furthermore, it mandates exploring mechanisms to access external biotechnology expertise, including prequalified experts with necessary security clearances. OPM must submit a report summarizing these findings and recommendations to relevant congressional committees within 180 days of the Act's enactment.